BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sakakura C, Hagiwara A, Soga K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yamaoka N, Sagara Y, Yamagishi H. Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy. World J Gastroenterol 2006; 12(17): 2793-2797 [PMID: 16718773 DOI: 10.3748/wjg.v12.i17.2793]
URL: https://www.wjgnet.com/1007-9327/full/v12/i17/2793.htm
Number Citing Articles
1
Sayantan Bhattacharya, Amit Kumar Choudhury, Srinivasan Ravi, John Morrissey, George Mathew. Six years survival on imatinib with no disease progression after diagnosis of metastatic duodenal gastrointestinal stromal tumour: A case reportJournal of Medical Case Reports 2008; 2(1) doi: 10.1186/1752-1947-2-110
2
D. Bassou, A. Darbi, A. Harket, M. Chamssi, T. Amezyane, J. El Fenni, K. Sair, S. Semlali, M. Atmane, H. Boumdin, M. Benameur, A. El Kharras. Tumeur stromale digestive : apport du scanner et corrélations pathologiquesFeuillets de Radiologie 2008; 48(1): 39 doi: 10.1016/S0181-9801(08)70318-X
3
Aikaterini Mastoraki, Eleftheria Toliaki, Eleni Chrisovergi, Sotiria Mastoraki, Ioannis S Papanikolaou, Nikolaos Danias, Vasilios Smyrniotis, Nikolaos Arkadopoulos. Metastatic Liver Disease Associated with Gastrointestinal Stromal Tumors: Controversies in Diagnostic and Therapeutic ApproachJournal of Gastrointestinal Cancer 2015; 46(3): 237 doi: 10.1007/s12029-015-9748-6
4
Masashi Inoue, Masayuki Shishida, Atsuhiro Watanabe, Ryujiro Kajikawa, Ryotaro Kajiwara, Hiroyuki Sawada, Ichiro Ohmori, Kazuaki Miyamoto, Masahiro Ikeda, Kazuhiro Toyota, Seiji Sadamoto, Tadateru Takahashi. A liver metastasis 7 years after resection of a low-risk duodenal gastrointestinal stromal tumorClinical Journal of Gastroenterology 2021; 14(5): 1464 doi: 10.1007/s12328-021-01464-w
5
Georgios S. Papaetis, Kostas N. Syrigos. Targeted therapy for gastrointestinal stromal tumors: current status and future perspectivesCancer and Metastasis Reviews 2010; 29(1): 151 doi: 10.1007/s10555-010-9206-7
6
Tohru Utsunomiya, Masahiro Okamoto, Shuya Yano, Toshihumi Kameyama, Ayumi Matsuyama, Sosei Kuma, Manabu Yamamoto, Megumu Fujiwara, Teruyoshi Ishida. Secondary c-kit Mutation in a Recurrent Gastrointestinal Stromal Tumor Under Long-Term Treatment with Imatinib Mesylate: Report of a CaseSurgery Today 2008; 38(1): 65 doi: 10.1007/s00595-007-3559-8
7
Zhen Liu, Gaozan Zheng, Jinqiang Liu, Shushang Liu, Guanghui Xu, Qiao Wang, Man Guo, Xiao Lian, Hongwei Zhang, Fan Feng. Clinicopathological features, surgical strategy and prognosis of duodenal gastrointestinal stromal tumors: a series of 300 patientsBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4485-4
8
Florence Duffaud, Axel Le Cesne. Imatinib in the treatment of solid tumoursTargeted Oncology 2009; 4(1): 45 doi: 10.1007/s11523-008-0101-x
9
Ying-jiang Ye, Zhi-dong Gao, G.J. Poston, Shan Wang. Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST)European Journal of Surgical Oncology (EJSO) 2009; 35(8): 787 doi: 10.1016/j.ejso.2009.01.003